| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |